ResMed Enhances CPAP Therapy With Its First Fabric Mask, Designed To Make It Easier For People To Embrace Their Treatment And Improve Overall Sleep Health
ResMed Enhances CPAP Therapy With Its First Fabric Mask, Designed To Make It Easier For People To Embrace Their Treatment And Improve Overall Sleep Health
ResMed (NYSE:RMD, ASX: RMD))))), the world's leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with the launch of the AirTouch N30i. Designed to create a natural and comfortable sleep experience for users, the AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design for optimal comfort in a tube-up design.
瑞思邁（紐交所：RMD, ASX: RMD))))))，全球領先的健康科技公司，專注於睡眠、呼吸和家庭護理，今日宣佈推出AirTouch N30i，這是瑞思邁在CPAP（持續氣道正壓）掩膜版-半導體創新方面的首次嘗試。AirTouch N30i旨在爲用戶創造自然舒適的睡眠體驗，採用包裹在織物中的框架，具有柔軟、透氣和吸溼性設計，以實現管上設計的最佳舒適度。
Sleep apnea affects more than 54 million people in the United States and nearly one billion people worldwide1. This chronic sleep-related breathing disorder can impair daily functioning and significantly increase the risk of serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke2.
睡眠呼吸暫停症在美國影響超過5千4百萬人，在全球範圍內近10億人受到影響。這種慢性與睡眠有關的呼吸障礙可能會影響日常功能並顯著增加嚴重合並症的風險，如高血壓、糖尿病、心血管疾病和中風。
譯文內容由第三人軟體翻譯。
